3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
250
Carcinoma, Renal Cell
89
Urinary Bladder Neoplasms
67
Breast Neoplasms
41
Carcinoma, Transitional Cell
37
Colorectal Neoplasms
33
Ovarian Neoplasms
32
Melanoma
31
Carcinoma, Non-Small-Cell Lung
31
Kidney Neoplasms
30
Neoplasms
28
Neoplasm Metastasis
26
Sarcoma
25
Uterine Cervical Neoplasms
20
Lung Neoplasms
20
Endometrial Neoplasms
20
Non-Muscle Invasive Bladder Neoplasms
19
Wilms Tumor
17
Adenocarcinoma
17
Stomach Neoplasms
16
Pancreatic Neoplasms
16
Carcinoma, Hepatocellular
16
Triple Negative Breast Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Metastatic Castration-resistant Prostate Cancer
13
Esophageal Neoplasms
13
Rhabdomyosarcoma
12
Osteosarcoma
12
Neuroblastoma
12
Head and Neck Neoplasms
12
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Progressive Metastatic Castrate Resistant Prostate Cancer
×
Genitourinary
×
30 days
×
Clear all
NCT07206056
2026-06-03
TulmiSTAR-01
Novartis
Phase 1/2
Recruiting
188 enrolled